Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Incorporació personal suport al grup Diabetis i metabolisme

IP: Rafael Simó Canonge
Collaborators: Miriam Izquierdo Sans
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 76000
Reference: SLT028/23/000272
Duration: 01/08/2023 - 31/12/2025

Plataforma de soporte para la Investigación Clínica

IP: Inmaculada Fuentes Camps
Collaborators: Antonio Moreno Galdó, Rafael Simó Canonge, Ariadna Martín Balcells, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi, Joan Genescà Ferrer, Gemma Vona Giralt, Paula Isabel Roldan Caballero
Funding agency: Instituto de Salud Carlos III
Funding: 274920
Reference: PT23/00062
Duration: 01/01/2024 - 31/12/2026

Retinal and cognitive dysfunction in type 2 diabetes

IP: Rafael Simó Canonge
Collaborators: Maria Llorian Salvador, Miriam Izquierdo Sans
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 152348.46
Reference: 2022 BP 00067
Duration: 01/04/2024 - 31/03/2027

Topical administration of sitagliptin in experimental models of diabetic retinopathy and glaucoma: delving into mechanisms of action and changing the therapeutic positioning (“Sit@Retina”).

IP: Rafael Simó Canonge
Collaborators: Maria Llorian Salvador
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 321250
Reference: PID2022-138544OB-I00
Duration: 01/09/2023 - 31/08/2026

Ministerio de Ciencia

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Andrea Casal Pardo

Andrea Casal Pardo

Predoctoral researcher
Kidney Physiopathology
Read more
Sergi Martí Beltran

Sergi Martí Beltran

Pneumology
Read more
Belén Moro

Belén Moro

P. Management and Admin. Technical specialist
Pre-Award Project Unit
Competitive Research Directorate
Read more
Miriam  Moratal  Cloquell

Miriam Moratal Cloquell

General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.